Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
FRLN was delisted on the 16th of February, 2024.
20 hedge funds and large institutions have $36.1M invested in Freeline Therapeutics Holdings plc American Depositary Shares in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 5 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
25% more funds holding
Funds holding: 16 → 20 (+4)
1.93% less ownership
Funds ownership: 31.56% → 29.63% (-1.9%)
61% less capital invested
Capital invested by funds: $91.6M → $36.1M (-$55.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$4.74M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$1.69M |
| 3 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$1.66M |
| 4 |
Renaissance Technologies
New York
|
+$922K |
| 5 |
Two Sigma Investments
New York
|
+$408K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.34M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$5.22M |
| 3 |
ABG
Ally Bridge Group
New York
|
-$3.27M |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$2.05M |
| 5 |
Millennium Management
New York
|
-$486K |
FRLN Hedge Fund Activity: Q3 2021 in Review
20 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) for Q3 2021, worth a combined $36.1M — down 61% from $91.6M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new FRLN positions and 5 closed out — a net gain of 4 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Eventide Asset Management, adding an estimated $4.74M. The largest seller was Wellington Management Group, cutting an estimated $6.34M.
- 20 institutional investors held Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) as of Q3 2021, up from 16 in Q2 2021.
- Funds reported $36.1M of Freeline Therapeutics Holdings plc American Depositary Shares stock for Q3 2021, down 61% quarter-over-quarter.
- 9 funds opened new Freeline Therapeutics Holdings plc American Depositary Shares positions in Q3 2021 and 5 closed out, a net change of +4 holders.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares buyer in Q3 2021 was Eventide Asset Management, an estimated $4.74M added.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares seller in Q3 2021 was Wellington Management Group, an estimated $6.34M sold.
Based on aggregated 13F filings for Q3 2021.